CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 237 SEK -0.84%
Market Cap: 5.7B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Revenue Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Revenue
kr726.4m
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
13%
Elekta AB (publ)
STO:EKTA B
Revenue
kr18.1B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Revenue
kr838.2m
CAGR 3-Years
82%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Revenue
kr31.8B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Revenue
kr11B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Revenue
kr429.7m
CAGR 3-Years
41%
CAGR 5-Years
24%
CAGR 10-Years
18%

See Also

What is CellaVision AB's Revenue?
Revenue
726.4m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Revenue amounts to 726.4m SEK.

What is CellaVision AB's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 21%. The average annual Revenue growth rates for CellaVision AB have been 14% over the past three years , 12% over the past five years , and 13% over the past ten years .

Back to Top